BRAF and colorectal carcinoma: In summary, this study indicates that IHC with the anti-BRAF V600E (VE1) antibody performed on the Benchmark ULTRA automated stainer is a highly sensitive and specific detection method for determination of BRAF V600E mutation status in CRC.